Navigation Links
Debiopharm Group™ and Aurigene Nominate Development Candidate
Date:9/13/2010

y science at Aurigene. It also paves the way for a larger synergistic alliance between the companies," added CSN Murthy, CEO of Aurigene.

About Debiopharm Group™ Debiopharm Group™ (Debiopharm) is a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs. The group in-licenses, develops and/or co-develops promising biological and small molecule drug candidates having reached clinical development phases I, II or III. Debiopharm is also prepared to consider earlier stage candidates. It develops its products for global registration and maximum commercial potential. The products are out-licensed to pharmaceutical partners for sales and marketing. Besides drug development, Debiopharm Group has recently embarked in the field of companion diagnostics with a view to progressing in the area of personalised medicine.

Debiopharm independently funds the worldwide development of all of its products while providing expertise in pre-clinical and clinical trials, manufacturing, drug delivery and formulation, and regulatory affairs.

For more information on Debiopharm Group™, please visit: www.debiopharm.com.

About AurigeneEstablished in Bangalore, India, in 2002, Aurigene Discovery Technologies Ltd. is a drug discovery biotech focused on small molecule and peptide drug discovery. With proprietary Structural Biology and Fragment-based Drug Design technology platforms, and experienced scientific leadership, Aurigene is a fully integrated Drug Discovery company focused on small molecule and peptide drug discovery and development from target identification and validation to pre-IND drug candidates in oncology, metabolic disorders, autoimmune diseases and anti-infectives.. Aurigene has- a proven track record of successful partnerships with big and medium-sized pharma and biotech companies globally. Auri
'/>"/>

SOURCE Debiopharm Group
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Debiopharm Group Grants an Exclusive Licence for the Development, Manufacture and Commercialisation of Debio 025
2. The Japanese Cancer Association and Debiopharm Group Present the JCA-Mauvernay Award to Dr Ushijima for his Oncology Research
3. Debiopharm Group and Mercury Therapeutics, Inc. Sign an Exclusive License Agreement for the Development and Commercialisation of Debio 0930
4. Swissmedic Grants Debiopharm Marketing Authorisation for Moapar(R), a New Therapeutic Avenue for the Treatment of Sexual Deviations
5. Swissmedic Grants Debiopharm Marketing Authorisation for Moapar(R), a New Therapeutic Avenue for the Treatment of Sexual Deviations
6. Salvacyl(R), Developed by Debiopharm, is Launched in two European Countries
7. Clinical Update - Debio 9902 SR (ZT-1) for Alzheimer Patients Debiopharm Starts Tablet Formulations Bridging Study under IND
8. Debiopharm Moves Towards a New 6-Month Formulation of Decapeptyl(R) to Further Help Prostate Cancer Patients
9. Debiopharm and EPFL Sign Research Project Agreement to Identify Inhibitors of Signalling Pathways Controlling Cell Fate for Cancer Treatment
10. Sinovacs CEO Weidong Yin Nominated for China Central Televisions Prestigious Economic Man-of-the-Year Award
11. Cardax Pharmaceuticals Nominates Clinical Candidate Heptax for Liver Disease; Heptax Ameliorates Inflammation and Oxidative Stress Related to Liver Disease and Metabolic Syndrome
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/5hkm2f/medical_oxygen ... Oxygen Systems - Global Strategic Business Report" report ... worldwide markets for Medical Oxygen Systems in US$ Thousands ... Oxygen Cylinders & Regulators, and Oxygen Conserving Devices. The ... Canada , Japan , ...
(Date:4/17/2015)... Va. , April 17, 2015   ... distribution of radiopharmaceuticals, announced today that it has signed ... Molecular North America, Inc. (IBAM NA), to Illinois Health and ... to operate as an independent company headquartered in ... positioned to take advantage of new product and footprint ...
(Date:4/17/2015)... 17, 2015 TWi Pharmaceuticals, Inc. ("TWi", Stock ... USA , has obtained state sales ... It has been in close contact with the major ... have its own label specialty generic products sold through ... pharma market. According to IMS Health, the ...
Breaking Medicine Technology:Medical Oxygen Systems - 2015 Global Strategic Business Report Featuring Leading Players, Caire, Invacare & Philips Respironics 2Health Care System to Acquire IBA Molecular North America 2Health Care System to Acquire IBA Molecular North America 3
... NEW YORK, Aug. 31 Reportlinker.com announces that ... its catalogue: Erectile Dysfunction - ... http://www.reportlinker.com/p0285103/Erectile-Dysfunction---Pipeline-Assessment-and-Market-Forecasts-to-2017.html Erectile ... 2017 SummaryGlobalData,s pharmaceutical and healthcare ...
... that a new market research report is available in ... Targeting the VEGF Pathway http://www.reportlinker.com/p0196624/Threats-to-Avastin---Targeting-the-VEGF-Pathway-.html ... successful cancer treatment to date and one of the ... by 2015. Since its launch in 2004, ...
Cached Medicine Technology:Reportlinker Adds Erectile Dysfunction - Pipeline Assessment and Market Forecasts to 2017 2Reportlinker Adds Erectile Dysfunction - Pipeline Assessment and Market Forecasts to 2017 3Reportlinker Adds Erectile Dysfunction - Pipeline Assessment and Market Forecasts to 2017 4Reportlinker Adds Erectile Dysfunction - Pipeline Assessment and Market Forecasts to 2017 5Reportlinker Adds Erectile Dysfunction - Pipeline Assessment and Market Forecasts to 2017 6Reportlinker Adds Threats to Avastin - Targeting the VEGF Pathway 2Reportlinker Adds Threats to Avastin - Targeting the VEGF Pathway 3Reportlinker Adds Threats to Avastin - Targeting the VEGF Pathway 4Reportlinker Adds Threats to Avastin - Targeting the VEGF Pathway 5Reportlinker Adds Threats to Avastin - Targeting the VEGF Pathway 6Reportlinker Adds Threats to Avastin - Targeting the VEGF Pathway 7Reportlinker Adds Threats to Avastin - Targeting the VEGF Pathway 8
(Date:4/19/2015)... A live auction will be held to sell ... in Brooklyn, NY and other national consignors. Various types of ... exam and much more. , The auction will take ... 9:00am CDT each day. The equipment is at their Chicago ... 60160. Anyone can participate in the auction including those ...
(Date:4/19/2015)... 19, 2015 Family and friends of Brad ... in Memory of Brad Baddeley event to honor his ... , Bowling for Brains is cheduled to take place on ... Street in Lincoln, Nebraska. Participants may arrive at 12:30pm on ... , The cost is only $4 per game and 100% ...
(Date:4/18/2015)... April 19, 2015 The Residential ... during the past five years. The industry, which provides ... unable to fully care for themselves, has boomed on ... for dementia care for seniors with memory impairment. As ... an annualized rate of 4.1% to $1.9 billion over ...
(Date:4/18/2015)... Carinsurancesavings.biz has released a new blog ... cheaper during Spring. , Spring can be a ... should make sure they compare the newest policies before ... learn more about Spring car insurance offers by reading ... quotes are becoming more and more popular. Many insurance ...
(Date:4/18/2015)... "I wanted to live a healthier ... juice that contained essential vitamins, minerals and nutrients," ... my energy, improves skin elasticity and gives me ... Juice to contain fruits, vegetables and other healthful ... mental fatigue. It features a great taste. The ...
Breaking Medicine News(10 mins):Health News:Centurion to Sell Surplus Medical Equipment in Online and On-Site Auction 2Health News:Lincoln, NE’s Bowling for Brains to benefit Renowned Brain Aneurysm Foundation 2Health News:Lincoln, NE’s Bowling for Brains to benefit Renowned Brain Aneurysm Foundation 3Health News:Residential Senior Care Franchises in the US Industry Market Research Report from IBISWorld Has Been Updated 2Health News:Residential Senior Care Franchises in the US Industry Market Research Report from IBISWorld Has Been Updated 3Health News:Auto Insurance Plans Are Cheaper During Spring! 2
... drug called bivalirudin (Angiomax) that beats the standard combination ... as heart// attacks. This new blood thinner seems to ... syndromes. ,The Results of the ‘Acute Catheterization ... in November issue of the New England Journal of ...
... taking a widely used medication to strengthen fragile, aging ... a recent study led by Johns Hopkins// rheumatologist Clifton ... risedronate might be used to treat osteoarthritis after noticing ... class of drugs, not only slowed joint damage in ...
... More than ever, children and adolescents are enjoying ... organized sport. Yet many observers have noted problems ... medicine physicians have seen alarming increases in sport-related ... the Clinical Journal of Sport Medicine is a ...
... new vaccine that promises protection against a wide range of ... a cell-based technology in 11 weeks time.The vaccine is capable ... virus. ,It is still in the early phase of clinical ... detected in many countries. It has caused maximum damage in ...
... The global AIDS epidemic continues to spiral with 4.3 million ... for 65 percent of the cases, states a new UNAIDS ... Geneva Tuesday estimates that globally 39.5 million people are living ... including the 960,000 people who became newly infected in the ...
... grouped the five major cities Vancouver//, Calgary, Toronto, ... features namely income, education, recent immigrants, people living ... observes neighbourhoods and housing conditions and other social ... ,The amount of greenery around, safety of ...
Cached Medicine News:Health News:New Anti-Clotting Drug Less Risky For Heart Attack Patients 2Health News:Millions with Arthritis May Benefit from Bone Loss Drug 2Health News:Kids in Sport—Great for Fitness, but Concern About Injurie 2Health News:Kids in Sport—Great for Fitness, but Concern About Injurie 3Health News:More then Four Million New HIV Infections in 2006: UNAIDS 2Health News:Health Of Residents Is Affected by Various Factors 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: